Neusoft COO: Merging High-Quality Datasets with AI Could Bolster Prevention of Rare Diseases

Deep News
5 hours ago

During the 2026 Yabuli Forum Summer Annual Meeting, held from September 4th to 6th in Chengdu, Sichuan, Neusoft Corporation Co-President and COO Gai Longjia stated that the healthcare industry holds vast potential globally. He emphasized that the core mission of AI technology is to "be seen," and that technology is currently redefining the position of humans and organizations within the social division of labor.

Gai Longjia noted that elderly care has emerged as a brand-new industry and undertaking. At the micro level, AI is empowering the development of specialized departments and disease-specific treatments in hospitals. By establishing specialized disease databases and high-quality datasets, combined with AI large models, hospitals can consolidate their knowledge and experience, ultimately benefiting every individual. He mentioned that the combination of high-quality datasets and AI technology could even provide technical support for the prevention of special diseases such as altitude sickness.

Addressing the social changes brought about by AI, Gai Longjia acknowledged that the rapid development of new technologies tends to generate anxiety. He stressed that the industry needs to redefine the position of humans and organizations within the social division of labor. He further emphasized that in the future, any pharmaceutical company claiming to be unrelated to AI might also find itself detached from the pharmaceutical industry altogether.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10